Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $CORT vs $RPRX | Chartloom

Compare

$CORT vs $RPRX

Corcept Therapeutics Inc · Royalty Pharma PLC

CORT

Corcept Therapeutics Inc

RPRX

Royalty Pharma PLC

Compare $CORT vs $RPRX

Comparing Corcept Therapeutics Inc and Royalty Pharma PLC

CORTCorcept Therapeutics Inc

RPRXRoyalty Pharma PLC

CORTCorcept Therapeutics Inc

Market cap

$12.73B

P/E (TTM)

252.72x

Forward P/E (NTM)

28.94x

Forward P/S (NTM)

8.27x

Rev growth (TTM)

16.0%

YTD performance

208.4%

52W performance

59.3%

FCF yield

0.8%

RPRXRoyalty Pharma PLC

Market cap

$32.57B

P/E (TTM)

38.65x

Forward P/E (NTM)

11.88x

Forward P/S (NTM)

9.72x

Rev growth (TTM)

10.0%

YTD performance

45.6%

52W performance

57.1%

FCF yield

1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CORT

RPRX

Detailed metrics comparison

CORT

Corcept Therapeutics Inc

RPRX

Royalty Pharma PLC

Market Cap

CORT$12.73B

RPRX$32.57B

Enterprise Value

CORT$12.62B

RPRX$40.72B

Price

CORT$117.80

RPRX$56.57

P/E Ratio

CORT252.72x

RPRX38.65x

P/S Ratio

CORT15.33x

RPRX12.84x

EV/Sales

CORT15.19x

RPRX16.06x

EV/EBITDA

CORT1,442.80x

RPRX25.19x

P/B Ratio

CORT18.56x

RPRX4.79x

P/FCF Ratio

CORT119.10x

RPRX56.41x

EV/FCF

CORT118.06x

RPRX70.52x

PEG Ratio

CORTN/A

RPRX3.89x

Forward P/E (NTM)

CORT28.94x

RPRX11.88x

Forward P/S (NTM)

CORT8.27x

RPRX9.72x

Revenue (TTM)

CORT$831M

RPRX$2.54B

Revenue Growth (YoY)

CORT16.0%

RPRX10.0%

Forward Rev Growth

CORT48.8%

RPRX5.2%

Gross Margin (TTM)

CORT98.3%

RPRX0.0%

Operating Margin (TTM)

CORT0.8%

RPRX59.6%

EBITDA Margin (TTM)

CORT1.0%

RPRX62.3%

Net Margin (TTM)

CORT6.6%

RPRX32.1%

FCF Margin (TTM)

CORT12.9%

RPRX22.8%

Net Income (TTM)

CORT$55M

RPRX$815M

FCF (TTM)

CORT$107M

RPRX$578M

EPS (TTM)

CORT$0.47

RPRX$1.46

ROE (TTM)

CORT8.4%

RPRX12.3%

ROA (TTM)

CORT6.6%

RPRX4.2%

ROIC (TTM)

CORT8.4%

RPRX5.2%

Cash

CORT$111M

RPRX$812M

Debt

CORT$0

RPRX$8.96B

Net Cash/Debt

CORT$111M

RPRX$-8.15B

Current Ratio (TTM)

CORT2.86x

RPRX2.80x

Quick Ratio (TTM)

CORT2.63x

RPRX2.80x

Debt/Equity (TTM)

CORT0.00x

RPRX1.31x

Debt/Assets (TTM)

CORT0.0%

RPRX0.0%

Interest Coverage (TTM)

CORTN/A

RPRXN/A

Net Debt/EBITDA (TTM)

CORT0.00x

RPRX0.00x

Beta

CORT0.52

RPRX0.39

52W Performance

CORT59.3%

RPRX57.1%

YTD Performance

CORT208.4%

RPRX45.6%

% from 52W High

CORT-6.8%

RPRX-12.1%

% from 52W Low

CORT311.0%

RPRX60.6%

Asset Turnover (TTM)

CORT0.99x

RPRX0.13x

FCF Yield (TTM)

CORT0.8%

RPRX1.8%

Earnings Yield (TTM)

CORT0.4%

RPRX2.5%

Dividend Yield (TTM)

CORTN/A

RPRX1.2%

Rule of 40

CORT28.9

RPRX32.8

EV/GP/RG

CORT0.18

RPRXN/A

Ticker research

View CORT research View RPRX research

Metric	CORT Corcept Therapeutics Inc	RPRX Royalty Pharma PLC
Market & Valuation
Market Cap	$12.73B	$32.57B
Enterprise Value	$12.62B	$40.72B
Price	$117.80	$56.57
P/E Ratio	252.72x	38.65x
P/S Ratio	15.33x	12.84x
EV/Sales	15.19x	16.06x
EV/EBITDA	1,442.80x	25.19x
P/B Ratio	18.56x	4.79x
P/FCF Ratio	119.10x	56.41x
EV/FCF	118.06x	70.52x
PEG Ratio	N/A	3.89x
Forward P/E (NTM)	28.94x	11.88x
Forward P/S (NTM)	8.27x	9.72x
Revenue & Growth
Revenue (TTM)	$831M	$2.54B
Revenue Growth (YoY)	16.0%	10.0%
Forward Rev Growth	48.8%	5.2%
Profitability
Gross Margin (TTM)	98.3%	0.0%
Operating Margin (TTM)	0.8%	59.6%
EBITDA Margin (TTM)	1.0%	62.3%
Net Margin (TTM)	6.6%	32.1%
FCF Margin (TTM)	12.9%	22.8%
Net Income (TTM)	$55M	$815M
FCF (TTM)	$107M	$578M
EPS (TTM)	$0.47	$1.46
ROE (TTM)	8.4%	12.3%
ROA (TTM)	6.6%	4.2%
ROIC (TTM)	8.4%	5.2%
Financial Health
Cash	$111M	$812M
Debt	$0	$8.96B
Net Cash/Debt	$111M	$-8.15B
Current Ratio (TTM)	2.86x	2.80x
Quick Ratio (TTM)	2.63x	2.80x
Debt/Equity (TTM)	0.00x	1.31x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	0.39
52W Performance	59.3%	57.1%
YTD Performance	208.4%	45.6%
% from 52W High	-6.8%	-12.1%
% from 52W Low	311.0%	60.6%
Efficiency & Yields
Asset Turnover (TTM)	0.99x	0.13x
FCF Yield (TTM)	0.8%	1.8%
Earnings Yield (TTM)	0.4%	2.5%
Dividend Yield (TTM)	N/A	1.2%
Other
Rule of 40	28.9	32.8
EV/GP/RG	0.18	N/A
Ticker research	View CORT research	View RPRX research

Valuation

P/E Ratio

RPRX

38.65x

CORT

252.72x

P/S Ratio

RPRX

12.84x

CORT

15.33x

EV/FCF

RPRX

70.52x

CORT

118.06x

Growth & revenue

Revenue Growth TTM

CORT

16.0%

RPRX

10.0%

Forward Revenue Growth

CORT

48.8%

RPRX

5.2%

Profitability & performance

Gross Margin

CORT

98.3%

RPRX

0.0%

ROE

RPRX

12.3%

CORT

8.4%

FCF Yield %

RPRX

1.8%

CORT

0.8%

52-Week Performance

CORT

59.3%

RPRX

57.1%

Detailed metrics comparison

CORT

Corcept Therapeutics Inc

RPRX

Royalty Pharma PLC

Market Cap

CORT$12.73B

RPRX$32.57B

Enterprise Value

CORT$12.62B

RPRX$40.72B

Price

CORT$117.80

RPRX$56.57

P/E Ratio

CORT252.72x

RPRX38.65x

P/S Ratio

CORT15.33x

RPRX12.84x

EV/Sales

CORT15.19x

RPRX16.06x

EV/EBITDA

CORT1,442.80x

RPRX25.19x

P/B Ratio

CORT18.56x

RPRX4.79x

P/FCF Ratio

CORT119.10x

RPRX56.41x

EV/FCF

CORT118.06x

RPRX70.52x

PEG Ratio

CORTN/A

RPRX3.89x

Forward P/E (NTM)

CORT28.94x

RPRX11.88x

Forward P/S (NTM)

CORT8.27x

RPRX9.72x

Revenue (TTM)

CORT$831M

RPRX$2.54B

Revenue Growth (YoY)

CORT16.0%

RPRX10.0%

Forward Rev Growth

CORT48.8%

RPRX5.2%

Gross Margin (TTM)

CORT98.3%

RPRX0.0%

Operating Margin (TTM)

CORT0.8%

RPRX59.6%

EBITDA Margin (TTM)

CORT1.0%

RPRX62.3%

Net Margin (TTM)

CORT6.6%

RPRX32.1%

FCF Margin (TTM)

CORT12.9%

RPRX22.8%

Net Income (TTM)

CORT$55M

RPRX$815M

FCF (TTM)

CORT$107M

RPRX$578M

EPS (TTM)

CORT$0.47

RPRX$1.46

ROE (TTM)

CORT8.4%

RPRX12.3%

ROA (TTM)

CORT6.6%

RPRX4.2%

ROIC (TTM)

CORT8.4%

RPRX5.2%

Cash

CORT$111M

RPRX$812M

Debt

CORT$0

RPRX$8.96B

Net Cash/Debt

CORT$111M

RPRX$-8.15B

Current Ratio (TTM)

CORT2.86x

RPRX2.80x

Quick Ratio (TTM)

CORT2.63x

RPRX2.80x

Debt/Equity (TTM)

CORT0.00x

RPRX1.31x

Debt/Assets (TTM)

CORT0.0%

RPRX0.0%

Interest Coverage (TTM)

CORTN/A

RPRXN/A

Net Debt/EBITDA (TTM)

CORT0.00x

RPRX0.00x

Beta

CORT0.52

RPRX0.39

52W Performance

CORT59.3%

RPRX57.1%

YTD Performance

CORT208.4%

RPRX45.6%

% from 52W High

CORT-6.8%

RPRX-12.1%

% from 52W Low

CORT311.0%

RPRX60.6%

Asset Turnover (TTM)

CORT0.99x

RPRX0.13x

FCF Yield (TTM)

CORT0.8%

RPRX1.8%

Earnings Yield (TTM)

CORT0.4%

RPRX2.5%

Dividend Yield (TTM)

CORTN/A

RPRX1.2%

Rule of 40

CORT28.9

RPRX32.8

EV/GP/RG

CORT0.18

RPRXN/A

Ticker research

View CORT research View RPRX research

Metric	CORT Corcept Therapeutics Inc	RPRX Royalty Pharma PLC
Market & Valuation
Market Cap	$12.73B	$32.57B
Enterprise Value	$12.62B	$40.72B
Price	$117.80	$56.57
P/E Ratio	252.72x	38.65x
P/S Ratio	15.33x	12.84x
EV/Sales	15.19x	16.06x
EV/EBITDA	1,442.80x	25.19x
P/B Ratio	18.56x	4.79x
P/FCF Ratio	119.10x	56.41x
EV/FCF	118.06x	70.52x
PEG Ratio	N/A	3.89x
Forward P/E (NTM)	28.94x	11.88x
Forward P/S (NTM)	8.27x	9.72x
Revenue & Growth
Revenue (TTM)	$831M	$2.54B
Revenue Growth (YoY)	16.0%	10.0%
Forward Rev Growth	48.8%	5.2%
Profitability
Gross Margin (TTM)	98.3%	0.0%
Operating Margin (TTM)	0.8%	59.6%
EBITDA Margin (TTM)	1.0%	62.3%
Net Margin (TTM)	6.6%	32.1%
FCF Margin (TTM)	12.9%	22.8%
Net Income (TTM)	$55M	$815M
FCF (TTM)	$107M	$578M
EPS (TTM)	$0.47	$1.46
ROE (TTM)	8.4%	12.3%
ROA (TTM)	6.6%	4.2%
ROIC (TTM)	8.4%	5.2%
Financial Health
Cash	$111M	$812M
Debt	$0	$8.96B
Net Cash/Debt	$111M	$-8.15B
Current Ratio (TTM)	2.86x	2.80x
Quick Ratio (TTM)	2.63x	2.80x
Debt/Equity (TTM)	0.00x	1.31x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.52	0.39
52W Performance	59.3%	57.1%
YTD Performance	208.4%	45.6%
% from 52W High	-6.8%	-12.1%
% from 52W Low	311.0%	60.6%
Efficiency & Yields
Asset Turnover (TTM)	0.99x	0.13x
FCF Yield (TTM)	0.8%	1.8%
Earnings Yield (TTM)	0.4%	2.5%
Dividend Yield (TTM)	N/A	1.2%
Other
Rule of 40	28.9	32.8
EV/GP/RG	0.18	N/A
Ticker research	View CORT research	View RPRX research